Ting-Yen Chao

Research Scientist
Seattle Children's Research Institute
Everett, Washington, United States

Ting-Yen Chao is a research scientist specializing in noviral gene therapy for Hemophilia A patients at the Seattle Children's Research Institute. With a focus on innovative treatments, Ting-Yen has played a pivotal role in advancing the field through the development and application of ultrasound-mediated gene therapy techniques for Hemophila A. The work promises transformative outcomes, offering the noval treatment possibilities for Hemophilia A patients.

Presentation(s):

• OC 11.5 - Lipid nanoparticles encapsulating FVIII transgene as re-dosable and safe gene therapy in hemophilia A

  Sunday, June 23, 2024
  10:30 – 10:45 ICT

• PB0207 - Enhancing FVIII Gene Therapy: Noninvasive Transcutaneous Ultrasound-Mediated Gene Delivery of Human Factor VIII Plasmid in Hemophilia A Mice

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0247 - Exploring Predictive Biomarkers for inhibitor development in Hemophilia A

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0248 - Reduced immunogenicity of FVIII through O-Glycopeptide Integration

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0263 - Treatment of Canine Hemophilia A via Intraosseous Delivery of a Platelet-Specific Factor VIII-Lentiviral Vector

  Sunday, June 23, 2024
  13:45 – 14:45 ICT